- AU$11.43m
- AU$17.21m
- AU$7.47m
Australia Stock Exchange release from RHINOMED : PRE_NR Ends: 08:24:07
Australia Stock Exchange release from RHINOMED : Rhinomed R&D refund
Australia Stock Exchange release from RHINOMED : Change of Director's Interest Notice - MJ
Brief: Rhinomed Posts Loss For Half-Year Attributable $5.5 Mln
Australia Stock Exchange release from RHINOMED : Half Yearly Report and Accounts
Australia Stock Exchange release from RHINOMED : Rhinomed releases half year results - 31 December 2020
Australia Stock Exchange release from RHINOMED : PRE_NR Ends: 13:17:51
Australia Stock Exchange release from RHINOMED : Change of Director's Interest Notice RD
Australia Stock Exchange release from RHINOMED : Appendix 4C - quarterly
Australia Stock Exchange release from RHINOMED : PRE_NR Ends: 09:41:24
Australia Stock Exchange release from RHINOMED : Appendix 3G MJ
Australia Stock Exchange release from RHINOMED : Appendix 3G - SS
Australia Stock Exchange release from RHINOMED : Change of Director's Interest Notice - MJ
Australia Stock Exchange release from RHINOMED : Change of Director's Interest Notice RD
Australia Stock Exchange release from RHINOMED : Change in substantial holding JMcB
Australia Stock Exchange release from RHINOMED : Change of Director's Interest Notice MJ
Australia's Rhinomed eyes best session in over 6 weeks on its nasal swab trial results
Australia Stock Exchange release from RHINOMED : Rhinoswab detects SARS-CoV-2 in Doherty Inst. RT-PCR study
Australia Stock Exchange release from RHINOMED : US OTCQB investor update